Loading...
Loading...
Among the 0 tracked institutional investors we monitor, IPHA (INNATE PHARMA S A) is held with a combined value of $0 across 0 shares.
Total Institutional Value
$0
Total Shares Held
0
Institutional Holders
0
| # | Fund | Value↓ | Portfolio % | Change |
|---|
Institutional investors hold $0 worth of IPHA stock across 0 positions. The largest institutional holder is N/A with $0 in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For IPHA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their IPHA positions.